The DOI matches its Crossref record; the references it cites are not checked yet.
Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews
Abstract
Objective: To systematically review the available literature on the pharmacological management of agitation and/or aggression in patients with traumatic brain injury (TBI), synthesize the available data, and provide guidelines. Design: Systematic review of systematic reviews. Main Measures: A literature review of the following websites was performed looking for systematic reviews on the treatment of agitation and/or aggression among patients with TBI: PubMed, CINAHL, DynaMed, Health Business Elite, and EBSCO (Psychology and behavioral sciences collection). Two researchers independently assessed articles for meeting inclusion/exclusion criteria. Data were extracted on year of publication, reviewed databases, dates of coverage, search limitations, pharmacological agents of interest, and a list of all controlled studies included. The included controlled studies were then examined to determine potential reasons for any difference in recommendations. Results: The literature review led to 187 citations and 67 unique publications after removing the duplicates. Following review of the title/abstracts and full texts, a total of 11 systematic reviews were included. The systematic reviews evaluated the evidence for safety and efficacy of the following medications: amantadine, amphetamines, methylphenidate, antiepileptics, atypical and typical antipsychotics, benzodiazepines, β-blockers, and sertraline. Conclusions: On the basis of the results of this literature review, the authors recommend avoiding benzodiazepines and haloperidol for treating agitation and/or aggression in the context of TBI. Atypical antipsychotics (olanzapine in particular) can be considered as practical alternatives for the as-needed management of agitation and/or aggression in lieu of benzodiazepines and haloperidol. Amantadine, β-blockers (propranolol and pindolol), antiepileptics, and methylphenidate can be considered for scheduled treatment of agitation and/or aggression in patients with TBI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Affective disorders represent the most prevalent psychopathological manifestations among combat veterans, emerging as a consequence of post-traumatic stress disorder (PTSD) [1-3] and traumatic brain injury (TBI) caused by blast exposure [4-6].”
From An individualized approach to the treatment of affective disorders in the comorbidity of post-traumatic stress disorder and traumatic brain injury (2024) · cites this paper as [6]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 64 · Cited by 43
Metadata
- Authors
- Rahmani, E., Lemelle, T. M., Samarbafzadeh, E., & Kablinger, A. S.
- Affiliations
- Georgetown University (US)
- East Carolina University (US)
- Venue
- Journal of Head Trauma Rehabilitation
- Published
- 2021-02-22
- Volume
- 36
- Issue
- 4
- Pages
- E262-E283
- ISSN
- 0885-9701 (ISSN-L)
- OpenAlex
- W3133939120
- Cited by
- 43
- References
- 64
- Citations by year
- 2026: 13 · 2025: 8 · 2024: 12 · 2023: 6 · 2022: 3 · 2021: 1
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Head Trauma Rehabilitation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Keywords
- traumatic brain injury, agitation, aggression, pharmacotherapy, benzodiazepines, haloperidol, atypical antipsychotics, olanzapine, amantadine, beta-blockers, propranolol, pindolol, antiepileptic drugs, methylphenidate, amphetamine, sertraline, treatment guidelines
- MeSH terms
- Brain Injuries, Traumatic, Systematic Reviews as Topic, Aggression, Humans, Psychomotor Agitation, Antipsychotic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews. https://app.cochat.ai/papers/10.1097/htr.0000000000000656
- The paper
- Rahmani, E., Lemelle, T. M., Samarbafzadeh, E., & Kablinger, A. S. (2021). Pharmacological Treatment of Agitation and/or Aggression in Patients With Traumatic Brain Injury: A Systematic Review of Reviews. Journal of Head Trauma Rehabilitation. https://doi.org/10.1097/htr.0000000000000656
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.